Journal of Natural Products · 2013 · 36 citations · 14 references
MedicineOphthalmologyPharmacologyOcular PharmacologyAge-related Macular DegenerationAntioxidant DefenseMacular DegenerationMacular DiseaseMacular DisordersOxidative Damage To BiomoleculesAge-related Macular ChangesAge-related Macular Degeneration PreventionAmine FunctionalizationAntioxidant InhibitionAntioxidant PharmacologyAntioxidant PropertiesPhotooxidationRetinal Pharmacology
Photooxidation of A2E may be involved in diseases of the macula, and antioxidants could serve as therapeutic agents for these diseases. Inhibitors of A2E photooxidation were prepared by Mannich reaction of the antioxidant quercetin. These compounds contain water-solubilizing amine groups, and several were more potent inhibitors of A2E photooxidation than quercetin.
14
James S. Wright, Erin R. Johnson, Gino A. DiLabio · Journal of the American Chemical Society · 2001 · 1.6K citations
Pharmacy, Biochemistry, Chemistry +15
A2E, a lipofuscin fluorophore, in human retinal pigmented epithelial cells in culture.
Janet R. Sparrow, Craig A. Parish, Masaru Hashimoto et al. · PubMed · 1999 · 317 citations
Involvement of oxidative mechanisms in blue-light-induced damage to A2E-laden RPE.
Janet R. Sparrow, Jilin Zhou, Shimon Ben‐Shabat et al. · PubMed · 2002 · 284 citations